1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA PCDH7 CTRPv2 pan-cancer AAC 0.089 0.01
mRNA STAU2 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA NUDT11 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA ACP6 CTRPv2 pan-cancer AAC 0.091 0.01
mRNA BOD1 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA NLRC3 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA TTC37 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA ANKRD29 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA NKX6-3 CTRPv2 pan-cancer AAC 0.09 0.01
mRNA WRN CTRPv2 pan-cancer AAC -0.094 0.01
Download CSV